Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/89e5c335-d324-4155-b8e3-f0d69cef579a/
JSLL
JEENA SIKHO LIFECARE LTDSnapshot 2026-07-12 · 0.6w · Fresh
Strategy Eligibility
2 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
Yes
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
CAQ 1.00
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
21.0%ile
P/E
33.2×
P/S
9.2×
P/B
15.8×
E/P
0.0403
FCF Yield
0.029
EBITDA/EV
0.048
SH Yield
0.002
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
85.00000000
/100 — 1=cheapest
VC2 (Trending Value)
83.00000000
/100
VC3 (Buyback)
84.00000000
/100
P/E of 33.2x is premium-priced — the market is paying up for expected growth. VC2 score of 83.00000000/100 — expensive across all six composite measures.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
99.0%ile
ROE
0.475
ROA
0.329
Net Margin
0.277
Op Margin
0.377
GPA
1.064
Current
3.25
F-Score
8/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.708
Earn Growth
1.775
Stability
0.318
lower=better
Accruals
-0.047
lower=better
5yr Consist
Yes
ROE of 47% is exceptional. F-Score of 8/9 indicates strong fundamental improvement across multiple dimensions.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
76.0%ile
6M Return
-12.6%
12M Return
7.1%
12-1 Mom
10.6%
Risk-Adj
0.23
Vol 252d
46.7%
Vol 60d
99.6%
↑ Expanding
Max DD 12M
-32.1%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
Near-term vol (100%) is expanding vs long-term (47%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.62
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare
· 160 peers
Sector Value %ile
44.1%
Sector Quality %ile
100.0%
P/E z-score
-0.21
P/B z-score
2.07
Sector Avg OS
41.5%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
| Symbol | Name | OS | Value | Quality | Momentum |
|---|---|---|---|---|---|
| LINCOLN | 97.0% | 89.0% | 80.0% | 79.0% | |
| NATCOPHARM | 96.0% | 86.0% | 88.0% | 68.0% | |
| VENUSREM | 96.0% | 68.0% | 95.0% | 99.0% | |
| SPARC | 96.0% | 71.0% | 91.0% | 94.0% | |
| STAR | 95.0% | 75.0% | 91.0% | 84.0% | |
| AUROPHARMA | 95.0% | 73.0% | 83.0% | 90.0% | |
| LUPIN | 94.0% | 64.0% | 98.0% | 86.0% | |
| SAGILITY | 93.0% | 78.0% | 87.0% | 64.0% |
Factor Interactions
Quality Momentum — Expensive
Strong quality (99th) and momentum (76th) but expensive (21th value). Premium priced — watch for mean reversion.
Quality at a Premium
High quality (99th) but expensive (21th value). Upside may be limited without earnings growth.
Volatility Expanding
60-day vol (100%) significantly exceeds 252-day (47%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
F
25.1% avg (7 factors)
Quality
A
97.0% avg (7 factors)
Momentum
D
35.3% avg (4 factors)
Risk
D
38.9% avg (1 factors)
High quality business commanding a premium price. The market recognises the quality — returns from here depend on continued fundamental execution. Momentum is weak, suggesting the market isn't yet buying this thesis. Patience required. Elevated risk profile — position sizing should reflect the higher volatility.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Score Trends6 snapshots
Factor Persistence6 snapshots
| Factor | Current | Streak | Trend | Spark |
|---|---|---|---|---|
| OS Composite | 0.620 | —0 | — | |
| Value %ile | 0.210 | —6 | — | |
| Quality %ile | 0.990 | —6 | — | |
| Momentum %ile | 0.760 | —6 | — | |
| F-Score | 8.000 | —6 | — | |
| Confidence | 0.920 | —6 | — | |
| Volatility | 0.467 | —6 | — |
Value Lens2021-07-13 → 2026-07-12
P/E Ratio
Earnings Yield
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
33.23
Earnings Yield (E/P)
0.0403
Price / Sales
9.20
Price / Book
15.78
Price / Cash Flow
29.05
FCF Yield
2.9%
EBITDA / EV
4.8%
Sales Yield (1/P·S)
0.1071
Shareholder Yield
Div + net buyback / mktcap
0.2%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
47.5%
Return on Assets
32.9%
Net Margin
27.7%
Operating Margin
37.7%
Gross Profit / Assets
Novy-Marx GPA
106.4%
Current Ratio
3.25
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.047
MomentumPrice trend strength over different horizons
6M Return
-12.6%
12M Return
7.1%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
10.6%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
0.23
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
70.8%
Earnings Growth (YoY)
177.5%
Earnings Stability (CV)
Lower = more stable
0.318
5yr Consistent
EPS up every year for 5 years
Yes
Piotroski F-Score
8
Dividend Yield
0.2%
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
85
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
83
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
84
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity